[ Price : $8.95]
FDA advisors say that Humiras benefits in treating ulcerative colitis outweigh its risks.[ Price : $8.95]
FDA Webview editor Jim Dickinson attracts strong support in his battle to keep providing FDA employees with the unique interactive...[ Price : $8.95]
Genentech files a BLA for trastuzumab emtansine, seeking approval to treat people with HER2-positive metastatic breast cancer.[ Price : $8.95]
FDA posts a draft guidance on questions and answers related to generic drug user fees.[ Price : $8.95]
CDER officials say they are not too concerned with European inspection findings and a subsequent recall involving Pacira Pharmaceu...[ Price : $8.95]
FDA slaps Genzyme with a refuse-to-file letter on a supplemental BLA for Lemtrada (alemtuzumab) as a treatment for relapsing multi...[ Price : $8.95]
FDA approves a Gilead Sciences NDA for Stribild, a once-a-day combination pill to treat HIV-1 infection in adults.[ Price : $8.95]
FDA lifts a clinical hold against Lpath and its iSonep, an anti-S1P monoclonal antibody that is being developed as a potential tre...